| Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study DK Nomah, J Reyes-Urueña, Y Díaz, S Moreno, J Aceiton, A Bruguera, ... The Lancet HIV 8 (11), e701-e710, 2021 | 96 | 2021 |
| Real-life experience with bictegravir/emtricitabine/tenofovir alafenamide in a large reference clinical centre J Ambrosioni, JR Liévano, L Berrocal, A Inciarte, L de la Mora, ... Journal of Antimicrobial Chemotherapy, 2022 | 34 | 2022 |
| High rate of long-term clinical events after ART resumption in HIV-positive patients exposed to antiretroviral therapy interruption V Richart, I Fernández, E de Lazzari, L Berrocal, C Fehér, M Plana, L Leal, ... AIDS, 2021 | 7* | 2021 |
| High rate of long-term clinical events after antiretroviral therapy resumption in HIV-positive patients exposed to antiretroviral therapy interruption V Richart, I Fernández, E de Lazzari, L Berrocal, C Fehér, M Plana, L Leal, ... AIDS 35 (15), 2463-2468, 2021 | 6 | 2021 |
| A prospective case-cohort study of COVID-19 in persons with HIV: CoVIH-19 study JL Blanco, JL Casado, JR Blanco, J Olalla, EL De Lazzari, LL Berrocal, ... Topics in Antiviral Medicine, 248-248, 2021 | 2 | 2021 |
| Experience from a real-life cohort: outcome of 984 HIV infected patients treated with bictegravir/emtricitabine/tenofovir alafenamide in Hospital Clinic, Barcelona J Rojas Lievano, L Berrocal, A Inciarte, L De la Mora, A Gonzalez-Cordon, ... JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 23, 24-25, 2020 | 2 | 2020 |
